ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Stem Cell and Granulocyte- Colony Stimulating Factor Therapies to Improve Functional Outcomes in Limb Transplantation

J. Weiss1, C. Phillips1, E. Malin1, V. Gorantla2, S. K. Salgar3

1Surgery, Madigan Army Medical Center, Tacoma, WA, 2Surgery, Wake Forest University, Salem, NC, 3Clinical Investigation, Madigan Army Medical Center, Tacoma, WA

Meeting: 2019 American Transplant Congress

Abstract number: A62

Keywords: Growth factors, Rat, Stem cells

Session Information

Date: Saturday, June 1, 2019

Session Name: Poster Session A: Basic & Clinical Science – VCA

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall C & D

Related Abstracts
  • Stem Cell and Novel Biologic Therapies to Enhance Functional Recovery in Limb Transplantation
  • Mesenchymal Stem Cell Therapy to Improve Functional Outcome in Vascular Composite Allotransplantation (VCA)

*Purpose: Although, over 200 clinical Vascularized Composite Allotransplantation (VCA) such as hands, legs, and face have been performed worldwide, still there are many challenges such as immune rejection and incomplete recovery of motor and sensory function. The objective of this study was to investigate whether adult Mesenchymal Stem Cells (MSCs) and Granulocyte-Colony Stimulating Factor (G-CSF) can improve limb functional outcomes in a rat sciatic nerve transection repair model.

*Methods: Under general anesthesia the right hind limb (femoral region) of the Lewis rat was exposed, the sciatic nerve was identified and transected; after an hour the epineurium of the proximal and distal ends of transected nerve were approximated using 10-O sutures. Bone marrow derived syngeneic MSCs (2 million/rat), G-CSF (50-100 µg/kg), and/or Vehicle were administered locally via hydrogel at the site of nerve repair, i.v./i.p., and to gastrocnemius muscle. The motor function was assessed by walking track analysis and sensory function by cutaneous pain reaction test. All animals received manual physiotherpay once a week 5-10 minutes and were group housed on wire mesh floor for 6-8 hours per day.

*Results: MSCs expanded ex vivo were CD29+, CD90+, CD34-, CD31-, MHC Class I+, Class II- and multipotent as determined by ex vivo differentiation in to adipocytes, osteocytes and chondrocytes. At two weeks post-nerve repair, total sensory function (peroneal, tibial, saphenous and sural) in all groups was ~1.8 on a scale of Grade 0-3 (0=No function; 3= Normal function); however, peroneal nerve function was ~ 2.8 (n=6/group). By 4 weeks total sensory function was 2.2±1.0 and 2.0±1.4 in MSC+G-CSF and MSC+vehicle groups, respectively. At 8 weeks, sensory function was restored to nearly normal in MSC+G-CSF (~2.8) but not in MSC+vehicle control (~2.3). At 8 weeks, motor function as determined by walking foot print grades 0-4 (0=no print; 4=heel plus 4-5 toe prints) was 3.2±1 and 1.8±1.2; and at 16 weeks 3.0±0.9 and 2.0±0.6 in MSC+G-CSF and MSC+vehicle groups, respectively. Motor function was significantly (P<0.05) improved in MSC+G-CSF treated group. Also, G-CSF administration to gastrocnemius muscle mitigated muscle atrophy markedly. Flexion contractures graded 0-4 (0= no contracture; 4= >90 degrees contracture) were significantly (P<0.01) reduced in G-CSF+MSC (1.5±0.8) treated animals compared to MSC+vehicle control (3.2±0.75). In a parallel study, we observed significant improvement in nerve regeneration by histology and functional outcomes with MSC therapy (n≥6) compared to vehicle alone controls.

*Conclusions: We believe MSC with G-CSF combination therapy can be successfully used to improve functional outcomes in limb transplantation and sciatic nerve injury.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Weiss J, Phillips C, Malin E, Gorantla V, Salgar SK. Stem Cell and Granulocyte- Colony Stimulating Factor Therapies to Improve Functional Outcomes in Limb Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/stem-cell-and-granulocyte-colony-stimulating-factor-therapies-to-improve-functional-outcomes-in-limb-transplantation/. Accessed April 20, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
    • Assessment of Anti-A and Anti-B Antibody Titers in Different IVIG Preparations: Correlation with Risk for Hemolysis

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy | Terms of Use

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.